Identification an innovative classification and nomogram for predicting the prognosis of thyroid carcinoma patients and providing therapeutic schedules

被引:0
|
作者
Feng, Zhanrong [1 ]
Zhao, Qian [1 ]
Ding, Ying [1 ]
Xu, Yue [1 ]
Sun, Xiaoxiao [1 ]
Chen, Qiang [1 ]
Zhang, Yang [1 ]
Miao, Juan [1 ]
Zhu, Jingjing [1 ]
机构
[1] Shuyang Cty Hosp Tradit Chinese Med, Dept Endocrinol, Shuyang 223600, Jiangsu, Peoples R China
关键词
Programmed cell death; Nomogram; thyroid carcinoma; Machine learning; Single cell transcriptome; Drug sensitivity; CELL-DEATH; CLASS-II; EXPRESSION;
D O I
10.1007/s00432-023-05252-6
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BackgroundThyroid carcinoma (THCA) represents a prevalent form of cancer globally, with its incidence demonstrating an upward trend in recent years. Accumulating evidence has indicated that programmed cell death (PCD) patterns exert a vital influence on tumor progression. Nevertheless, the association between PCD and the prognosis of patients with papillary thyroid carcinoma remains to be elucidated. The current study endeavors to examine the link between PCD and the prognosis of thyroid cancer while concurrently developing a prognostic index based on PCD genes.Materials and methodsProgrammed cell death patterns were employed to construct the model and define clusters. Gene expression profile genomics and clinical data pertaining to 568 patients with thyroid cancer were sourced from the TCGA database. In addition, single-cell transcriptome data GSE184362 were procured from the Gene Expression Omnibus (GEO) database for subsequent analysis.ResultsThe study harnessed six machine learning algorithms to create a programmed cell death signature (PCDS). Ultimately, the model developed via SVM was chosen as the optimal model, boasting the highest C-index. Moreover, the application of non-negative matrix factorization (NMF) led to the identification of two molecular subtypes of THCA, each characterized by distinct vital biological processes and drug sensitivities. The investigation revealed that PCDS is linked to chemokines, interleukins, interferons, and checkpoint genes, as well as pivotal components of the tumor microenvironment, as determined through a comprehensive analysis of bulk and single-cell transcriptomes. Patients with THCA and elevated PCDS values are more inclined to exhibit resistance to conventional chemotherapy regimens, yet may display heightened responsiveness to targeted therapeutic agents. Finally, we established a nomogram model based on multivariable cox and logistic regression analyses to predict the overall survival of THCA patients.ConclusionThis research sheds new light on the role of programmed cell death (PCD) patterns in THCA. By conducting an in-depth analysis of various cell death patterns, a novel PCD model has been devised, capable of accurately predicting the clinical prognosis and drug sensitivity of patients with THCA.
引用
收藏
页码:14817 / 14831
页数:15
相关论文
共 50 条
  • [41] FACTORS AFFECTING THE PROGNOSIS OF PATIENTS WITH CARCINOMA OF THE THYROID
    ITO, J
    NOGUCHI, S
    MURAKAMI, N
    NOGUCHI, A
    SURGERY GYNECOLOGY & OBSTETRICS, 1980, 150 (04): : 539 - 544
  • [42] Identification of an immune gene signature for predicting the prognosis of patients with uterine corpus endometrial carcinoma
    Cankun Zhou
    Chaomei Li
    Fangli Yan
    Yuhua Zheng
    Cancer Cell International, 20
  • [43] Identification of a glycolysis-related gene signature for predicting prognosis in patients with hepatocellular carcinoma
    Junjie Kong
    Guangsheng Yu
    Wei Si
    Guangbing Li
    Jiawei Chai
    Yong Liu
    Jun Liu
    BMC Cancer, 22
  • [44] Identification of Immune Subtypes for Predicting the Prognosis of Patients in Head and Neck Squamous Cell Carcinoma
    Sun, Jing
    Fang, Guiqing
    Zuo, Zhibin
    Yu, Xijiao
    Xue, Lande
    Li, Chong
    Li, Shu
    TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2021, 20
  • [45] Identification of an immune gene signature for predicting the prognosis of patients with uterine corpus endometrial carcinoma
    Zhou, Cankun
    Li, Chaomei
    Yan, Fangli
    Zheng, Yuhua
    CANCER CELL INTERNATIONAL, 2020, 20 (01)
  • [46] Identification of a glycolysis-related gene signature for predicting prognosis in patients with hepatocellular carcinoma
    Kong, Junjie
    Yu, Guangsheng
    Si, Wei
    Li, Guangbing
    Chai, Jiawei
    Liu, Yong
    Liu, Jun
    BMC CANCER, 2022, 22 (01)
  • [47] External validation of a nomogram predicting mortality in patients with adrenocortical carcinoma
    Zini, Laurent
    Capitanio, Umberto
    Jeldres, Claudio
    Lughezzani, Giovanni
    Sun, Maxine
    Shariat, Shahrokh F.
    Isbarn, Hendrik
    Arjane, Philippe
    Widmer, Hugues
    Perrotte, Paul
    Graefen, Markus
    Montorsi, Francesco
    Karakiewicz, Pierre I.
    BJU INTERNATIONAL, 2009, 104 (11) : 1661 - 1667
  • [48] A nomogram for predicting survival of nasopharyngeal carcinoma patients with metachronous metastasis
    Zeng, Zixun
    Shen, Lujun
    Wang, Yue
    Shi, Feng
    Chen, Chen
    Wu, Ming
    Bai, Yutong
    Pan, Changchuan
    Xia, Yunfei
    Wu, Peihong
    Li, Wang
    MEDICINE, 2016, 95 (27)
  • [49] A metabolism-related gene signature for predicting the prognosis and therapeutic responses in patients with hepatocellular carcinoma
    Dai, Xiaoyan
    Jiang, Wei
    Ma, Liang
    Sun, Jie
    Yan, Xiaodi
    Qian, Jing
    Wang, Yan
    Shi, Yu
    Ni, Shujie
    Yao, Ninghua
    ANNALS OF TRANSLATIONAL MEDICINE, 2021, 9 (06)
  • [50] Development and Validation of a Radiomic Nomogram for Predicting the Prognosis of Kidney Renal Clear Cell Carcinoma
    Gao, Ruizhi
    Qin, Hui
    Lin, Peng
    Ma, Chenjun
    Li, Chengyang
    Wen, Rong
    Huang, Jing
    Wan, Da
    Wen, Dongyue
    Liang, Yiqiong
    Huang, Jiang
    Li, Xin
    Wang, Xinrong
    Chen, Gang
    He, Yun
    Yang, Hong
    FRONTIERS IN ONCOLOGY, 2021, 11